INVO Fertility (IVF) Cash from Investing Activities Growth (1y) (2020 - 2026)
INVO Fertility (IVF) Cash from Investing Activities Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -15.64% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -514.42% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -73.71% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -12.26% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 618.55% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 48.43% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 91.33% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 0.00% |
| 10 | INVO Fertility | 2.38 Mn | 2.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,333.45% |
| Jun 30, 2025 | -201.03% |
| Mar 31, 2025 | 39.23% |
| Dec 31, 2024 | 1,080.94% |
| Jun 30, 2024 | 98.04% |
| Mar 31, 2024 | -185.40% |
| Dec 31, 2023 | 287.86% |
| Sep 30, 2023 | -74,973.70% |
| Jun 30, 2023 | -5,234.66% |
| Mar 31, 2023 | 89.68% |
| Dec 31, 2022 | 100.94% |
| Sep 30, 2022 | 99.06% |
| Jun 30, 2022 | 99.19% |
| Mar 31, 2022 | 73.50% |
| Dec 31, 2021 | -850.42% |
| Sep 30, 2021 | -425.48% |
| Jun 30, 2021 | -13,097.02% |
| Mar 31, 2021 | -1,129.28% |
| Sep 30, 2020 | -22.23% |
| Jun 30, 2020 | 72.05% |